Cheryl L. Morse

4.1k total citations · 1 hit paper
79 papers, 3.0k citations indexed

About

Cheryl L. Morse is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Cheryl L. Morse has authored 79 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Cheryl L. Morse's work include Neuroscience and Neuropharmacology Research (19 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Drug Transport and Resistance Mechanisms (16 papers). Cheryl L. Morse is often cited by papers focused on Neuroscience and Neuropharmacology Research (19 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Drug Transport and Resistance Mechanisms (16 papers). Cheryl L. Morse collaborates with scholars based in United States, Sweden and South Korea. Cheryl L. Morse's co-authors include Victor W. Pike, Robert B. Innis, Sami S. Zoghbi, William Charles Kreisl, Chul Hyoung Lyoo, Kimberly J. Jenko, Jussi Hirvonen, Masahiro Fujita, Garth E. Terry and Jeih-San Liow and has published in prestigious journals such as Nature Communications, PLoS ONE and NeuroImage.

In The Last Decade

Cheryl L. Morse

77 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

2011 424 citations Jussi Hirvonen, Robert S. Goodwin et al. Molecular Psychiatry profile →

Peers

Cheryl L. Morse

CMN

PHARM

NEURO

PHYSI

Jinsoo Hong United States

Michel Bottlaender France

Devin Welty United States

Cheryl A. Hawkes United Kingdom

Robert C. Schuit Netherlands

Shu-fei Lin United States

Jim Ropchan United States

Johannes Streffer Belgium

Randall L. Woltjer United States

Christine A. Parker United Kingdom

Jinsoo Hong United States

Cheryl L. Morse

706 ×0.8

CMN

762 ×1.0

245 ×0.3

PHARM

349 ×0.5

NEURO

320 ×0.5

PHYSI

Citations per year, relative to Cheryl L. Morse Cheryl L. Morse (= 1×) peers Jinsoo Hong

Countries citing papers authored by Cheryl L. Morse

Since Specialization

Citations

This map shows the geographic impact of Cheryl L. Morse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl L. Morse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl L. Morse more than expected).

Fields of papers citing papers by Cheryl L. Morse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl L. Morse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl L. Morse. The network helps show where Cheryl L. Morse may publish in the future.

Co-authorship network of co-authors of Cheryl L. Morse

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl L. Morse. A scholar is included among the top collaborators of Cheryl L. Morse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl L. Morse. Cheryl L. Morse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Qunchao, et al.. (2024). Isotopologues of potassium 2,2,2-trifluoroethoxide for applications in positron emission tomography and beyond. Nature Communications. 15(1). 5798–5798. 4 indexed citations

Yan, Xuefeng, Fabrice G. Siméon, Jeih-San Liow, et al.. (2024). [ ¹⁸ F]SF51, a novel ¹⁸ F-labeled PET radioligand for translocator protein 18kDa (TSPO) in brain, works well in monkeys but fails in humans. Journal of Cerebral Blood Flow & Metabolism. 45(2). 365–372.

Lerchner, Walter, Paolo Zanotti‐Fregonara, Jeih‐San Liow, et al.. (2024). Evaluation of [18F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brain. Molecular Therapy. 32(7). 2223–2231.

Yan, Xuefeng, Fabrice G. Siméon, Jeih‐San Liow, et al.. (2023). In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain. European Journal of Nuclear Medicine and Molecular Imaging. 50(10). 2962–2970. 5 indexed citations

Siméon, Fabrice G., Jae‐Hoon Lee, Cheryl L. Morse, et al.. (2021). Synthesis and Screening in Mice of Fluorine-Containing PET Radioligands for TSPO: Discovery of a Promising ¹⁸F-Labeled Ligand. Journal of Medicinal Chemistry. 64(22). 16731–16745. 17 indexed citations

Hong, Jinsoo, Sanjay Telu, Yi Zhang, et al.. (2021). Translation of 11C-labeled tracer synthesis to a CGMP environment as exemplified by [11C]ER176 for PET imaging of human TSPO. Nature Protocols. 16(9). 4419–4445. 9 indexed citations

Telu, Sanjay, et al.. (2019). A Gas Phase Route to [18F]fluoroform with Limited Molar Activity Dilution. Scientific Reports. 9(1). 14835–14835. 21 indexed citations

Brouwer, Chad, Kimberly J. Jenko, Sami S. Zoghbi, et al.. (2016). Translocator protein ligands based on N -methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development. European Journal of Medicinal Chemistry. 124. 677–688. 2 indexed citations

Kreisl, William Charles, Chul Hyoung Lyoo, Jeih-San Liow, et al.. (2016). Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer's disease. Neurobiology of Aging. 51. 132–140. 37 indexed citations

10.

Kreisl, William Charles, Chul Hyoung Lyoo, Jeih-San Liow, et al.. (2016). 11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease. Neurobiology of Aging. 44. 53–61. 132 indexed citations

11.

Zanotti‐Fregonara, Paolo, Jussi Hirvonen, Chul Hyoung Lyoo, et al.. (2014). Population-Based Input Function Modeling for [18F]FMPEP-d2, an Inverse Agonist Radioligand for Cannabinoid CB1 Receptors: Validation in Clinical Studies. YUHSpace (Yonsei University Medical Library). 29 indexed citations

12.

Shrestha, Saurav, Jeih‐San Liow, Shuiyu Lu, et al.. (2014). ¹¹C-CUMI-101, a PET Radioligand, Behaves as a Serotonin 1A Receptor Antagonist and Also Binds to α₁Adrenoceptors in Brain. Journal of Nuclear Medicine. 55(1). 141–146. 17 indexed citations

13.

Zanotti‐Fregonara, Paolo, Jussi Hirvonen, Chul Hyoung Lyoo, et al.. (2013). Population-Based Input Function Modeling for [18F]FMPEP-d2, an Inverse Agonist Radioligand for Cannabinoid CB1 Receptors: Validation in Clinical Studies. PLoS ONE. 8(4). e60231–e60231. 4 indexed citations

14.

Kreisl, William Charles, Chul Hyoung Lyoo, Joseph Snow, et al.. (2013). In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain. 136(7). 2228–2238. 274 indexed citations

15.

Hines, Christina S., Masahiro Fujita, Sami S. Zoghbi, et al.. (2012). Propofol Decreases In Vivo Binding of ¹¹C-PBR28 to Translocator Protein (18 kDa) in the Human Brain. Journal of Nuclear Medicine. 54(1). 64–69. 27 indexed citations

16.

Bao, Xiaofeng, Shuiyu Lu, Jeih‐San Liow, et al.. (2012). [11C]Rhodamine-123: Synthesis and biodistribution in rodents. Nuclear Medicine and Biology. 39(8). 1128–1136. 15 indexed citations

17.

Hirvonen, Jussi, Paolo Zanotti‐Fregonara, John C. Umhau, et al.. (2012). Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Molecular Psychiatry. 18(8). 916–921. 103 indexed citations

18.

Hirvonen, Jussi, Robert S. Goodwin, Cheng‐Ta Li, et al.. (2011). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry. 17(6). 642–649. 424 indexed citations breakdown →

19.

Kannan, Pavitra, Kyle R. Brimacombe, Sami S. Zoghbi, et al.. (2010). N-desmethyl-Loperamide Is Selective for P-Glycoprotein among Three ATP-Binding Cassette Transporters at the Blood-Brain Barrier. Drug Metabolism and Disposition. 38(6). 917–922. 38 indexed citations

20.

Terry, Garth E., Jussi Hirvonen, Jeih‐San Liow, et al.. (2009). Imaging and Quantitation of Cannabinoid CB₁ Receptors in Human and Monkey Brains Using ¹⁸F-Labeled Inverse Agonist Radioligands. Journal of Nuclear Medicine. 51(1). 112–120. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact